nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—FPR1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0569	0.0925	CbGpPWpGaD
Nedocromil—PTGDR—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0549	0.0893	CbGpPWpGaD
Nedocromil—FPR1—nervous system—Gilles de la Tourette syndrome	0.0542	0.141	CbGeAlD
Nedocromil—FPR1—central nervous system—Gilles de la Tourette syndrome	0.0521	0.135	CbGeAlD
Nedocromil—PTGDR—nervous system—Gilles de la Tourette syndrome	0.0511	0.133	CbGeAlD
Nedocromil—PTGDR—central nervous system—Gilles de la Tourette syndrome	0.0492	0.128	CbGeAlD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0431	0.0701	CbGpPWpGaD
Nedocromil—PTGDR—brain—Gilles de la Tourette syndrome	0.0391	0.102	CbGeAlD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0299	0.0486	CbGpPWpGaD
Nedocromil—HSP90AA1—midbrain—Gilles de la Tourette syndrome	0.0239	0.0621	CbGeAlD
Nedocromil—CYSLTR1—nervous system—Gilles de la Tourette syndrome	0.0226	0.0588	CbGeAlD
Nedocromil—CYSLTR1—central nervous system—Gilles de la Tourette syndrome	0.0218	0.0566	CbGeAlD
Nedocromil—HSP90AA1—nervous system—Gilles de la Tourette syndrome	0.0196	0.051	CbGeAlD
Nedocromil—HSP90AA1—central nervous system—Gilles de la Tourette syndrome	0.0189	0.0491	CbGeAlD
Nedocromil—CYSLTR1—brain—Gilles de la Tourette syndrome	0.0173	0.045	CbGeAlD
Nedocromil—HSP90AA1—brain—Gilles de la Tourette syndrome	0.015	0.039	CbGeAlD
Nedocromil—FPR1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0101	0.0164	CbGpPWpGaD
Nedocromil—FPR1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00979	0.0159	CbGpPWpGaD
Nedocromil—FPR1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00936	0.0152	CbGpPWpGaD
Nedocromil—FPR1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00912	0.0148	CbGpPWpGaD
Nedocromil—FPR1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00909	0.0148	CbGpPWpGaD
Nedocromil—PTGDR—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00904	0.0147	CbGpPWpGaD
Nedocromil—PTGDR—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00878	0.0143	CbGpPWpGaD
Nedocromil—FPR1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00847	0.0138	CbGpPWpGaD
Nedocromil—PTGDR—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00818	0.0133	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00802	0.013	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00779	0.0127	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00775	0.0126	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00752	0.0122	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00725	0.0118	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0071	0.0115	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00701	0.0114	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00689	0.0112	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00642	0.0104	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00611	0.00993	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00608	0.00989	CbGpPWpGaD
Nedocromil—FPR1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00593	0.00964	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00593	0.00964	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0059	0.0096	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0059	0.00959	CbGpPWpGaD
Nedocromil—HSP90AA1—Semaphorin interactions—MET—Gilles de la Tourette syndrome	0.00586	0.00953	CbGpPWpGaD
Nedocromil—CYSLTR2—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00581	0.00945	CbGpPWpGaD
Nedocromil—PTGDR—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00573	0.00931	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00573	0.00931	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00552	0.00898	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0055	0.00894	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00534	0.00868	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0052	0.00846	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00512	0.00833	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00508	0.00826	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00492	0.008	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00491	0.00798	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00477	0.00776	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00463	0.00753	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00449	0.00731	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00449	0.00731	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00445	0.00723	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00421	0.00685	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00419	0.00681	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00409	0.00665	CbGpPWpGaD
Nedocromil—CYSLTR1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00403	0.00655	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00387	0.00629	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00385	0.00626	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00381	0.0062	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00374	0.00608	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0036	0.00586	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00345	0.00561	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00335	0.00545	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00333	0.00542	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00324	0.00526	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00321	0.00522	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00313	0.0051	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00312	0.00508	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00312	0.00507	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00312	0.00507	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00304	0.00495	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00303	0.00492	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00302	0.0049	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00294	0.00478	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00293	0.00477	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0029	0.00472	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00283	0.00461	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00274	0.00445	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00267	0.00434	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00262	0.00425	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00254	0.00413	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00238	0.00386	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00237	0.00385	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00231	0.00375	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00221	0.00359	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00219	0.00356	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00215	0.00349	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00211	0.00343	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00203	0.0033	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00199	0.00323	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00192	0.00312	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00185	0.00301	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00181	0.00295	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0018	0.00292	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00179	0.00291	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00176	0.00286	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00174	0.00282	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00167	0.00272	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MET—Gilles de la Tourette syndrome	0.00166	0.0027	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00166	0.00269	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00165	0.00268	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00164	0.00267	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00162	0.00263	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0016	0.0026	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.0015	0.00245	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00149	0.00242	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.0014	0.00228	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00136	0.00222	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00127	0.00206	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.00119	0.00193	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00117	0.00191	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00115	0.00187	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00113	0.00184	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00104	0.0017	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000973	0.00158	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000944	0.00154	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000889	0.00145	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00088	0.00143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000698	0.00114	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000678	0.0011	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000631	0.00103	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000616	0.001	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000442	0.000719	CbGpPWpGaD
